BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

185 related articles for article (PubMed ID: 12010961)

  • 1. Mapping and sequencing of the canine NRAMP1 gene and identification of mutations in leishmaniasis-susceptible dogs.
    Altet L; Francino O; Solano-Gallego L; Renier C; Sánchez A
    Infect Immun; 2002 Jun; 70(6):2763-71. PubMed ID: 12010961
    [TBL] [Abstract][Full Text] [Related]  

  • 2. cDNA sequencing and expression of Nramp1 (Slc11a1) in dogs phenotypically resistant or susceptible to visceral leishmaniasis.
    Bueno R; Carvalho Neta AV; Xavier MN; Oliveira RG; Diniz SA; Melo MN; Santos RL
    Vet Immunol Immunopathol; 2009 Feb; 127(3-4):332-9. PubMed ID: 19084282
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Slc11a1 (formerly Nramp1) and susceptibility to canine visceral leishmaniasis.
    Sanchez-Robert E; Altet L; Utzet-Sadurni M; Giger U; Sanchez A; Francino O
    Vet Res; 2008; 39(3):36. PubMed ID: 18307968
    [TBL] [Abstract][Full Text] [Related]  

  • 4. SLC11A1 polymorphisms and susceptibility to visceral leishmaniasis in Moroccan patients.
    Ejghal R; Hida M; Idrissi ML; Hessni AE; Lemrani M
    Acta Trop; 2014 Dec; 140():130-6. PubMed ID: 25151047
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mapping of the antigenic determinants of the Leishmania infantum gp63 protein recognized by antibodies elicited during canine visceral leishmaniasis.
    Morales G; Carrillo G; Requena JM; Guzman F; Gomez LC; Patarroyo ME; Alonso C
    Parasitology; 1997 Jun; 114 ( Pt 6)():507-16. PubMed ID: 9172421
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Polymorphism of Slc11a1 (Nramp1) gene and canine leishmaniasis in a case-control study.
    Sanchez-Robert E; Altet L; Sanchez A; Francino O
    J Hered; 2005; 96(7):755-8. PubMed ID: 16251521
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification and characterization of new Leishmania promastigote surface antigens, LaPSA-38S and LiPSA-50S, as major immunodominant excreted/secreted components of L. amazonensis and L. infantum.
    Bras-Gonçalves R; Petitdidier E; Pagniez J; Veyrier R; Cibrelus P; Cavaleyra M; Maquaire S; Moreaux J; Lemesre JL
    Infect Genet Evol; 2014 Jun; 24():1-14. PubMed ID: 24614507
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Antigenicity of the Leishmania infantum histones H2B and H4 during canine viscerocutaneous leishmaniasis.
    Soto M; Requena JM; Quijada L; Perez MJ; Nieto CG; Guzman F; Patarroyo ME; Alonso C
    Clin Exp Immunol; 1999 Feb; 115(2):342-9. PubMed ID: 9933463
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Identification of the Leishmania infantum P0 ribosomal protein epitope in canine visceral leishmaniasis.
    Soto M; Requena JM; Quijada L; Guzman F; Patarroyo ME; Alonso C
    Immunol Lett; 1995 Nov; 48(1):23-8. PubMed ID: 8847086
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Examining the role of components of Slc11a1 (Nramp1) in the susceptibility of New Zealand sea lions (Phocarctos hookeri) to disease.
    Osborne AJ; Pearson J; Chilvers BL; Kennedy MA; Gemmell NJ
    PLoS One; 2015; 10(4):e0122703. PubMed ID: 25874773
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Canine visceral leishmaniasis: asymptomatic infected dogs as a source of L. infantum infection.
    Moshfe A; Mohebali M; Edrissian G; Zarei Z; Akhoundi B; Kazemi B; Jamshidi S; Mahmoodi M
    Acta Trop; 2009 Nov; 112(2):101-5. PubMed ID: 19595664
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Long-lasting protection against canine visceral leishmaniasis using the LiESAp-MDP vaccine in endemic areas of France: double-blind randomised efficacy field trial.
    Lemesre JL; Holzmuller P; Gonçalves RB; Bourdoiseau G; Hugnet C; Cavaleyra M; Papierok G
    Vaccine; 2007 May; 25(21):4223-34. PubMed ID: 17395339
    [TBL] [Abstract][Full Text] [Related]  

  • 13. SLC11A1 (formerly NRAMP1) and susceptibility to visceral leishmaniasis in The Sudan.
    Mohamed HS; Ibrahim ME; Miller EN; White JK; Cordell HJ; Howson JM; Peacock CS; Khalil EA; El Hassan AM; Blackwell JM
    Eur J Hum Genet; 2004 Jan; 12(1):66-74. PubMed ID: 14523377
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An immunoproteomic approach to identifying immunoreactive proteins in
    Rashidi S; Mojtahedi Z; Shahriari B; Kalantar K; Ghalamfarsa G; Mohebali M; Hatam G
    Pathog Glob Health; 2019 May; 113(3):124-132. PubMed ID: 31099725
    [TBL] [Abstract][Full Text] [Related]  

  • 15. HIF-1 regulates heritable variation and allele expression phenotypes of the macrophage immune response gene SLC11A1 from a Z-DNA forming microsatellite.
    Bayele HK; Peyssonnaux C; Giatromanolaki A; Arrais-Silva WW; Mohamed HS; Collins H; Giorgio S; Koukourakis M; Johnson RS; Blackwell JM; Nizet V; Srai SK
    Blood; 2007 Oct; 110(8):3039-48. PubMed ID: 17606764
    [TBL] [Abstract][Full Text] [Related]  

  • 16. The human Nramp2 gene: characterization of the gene structure, alternative splicing, promoter region and polymorphisms.
    Lee PL; Gelbart T; West C; Halloran C; Beutler E
    Blood Cells Mol Dis; 1998 Jun; 24(2):199-215. PubMed ID: 9642100
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Characterization of the antigenic determinants of the Leishmania infantum histone H3 recognized by antibodies elicited during canine visceral leishmaniasis.
    Soto M; Requena JM; Quijada L; Gomez LC; Guzman F; Patarroyo ME; Alonso C
    Clin Exp Immunol; 1996 Dec; 106(3):454-61. PubMed ID: 8973612
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Transcription of innate immunity genes and cytokine secretion by canine macrophages resistant or susceptible to intracellular survival of Leishmania infantum.
    Turchetti AP; da Costa LF; Romão Ede L; Fujiwara RT; da Paixão TA; Santos RL
    Vet Immunol Immunopathol; 2015 Jan; 163(1-2):67-76. PubMed ID: 25466388
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Canine Leishmania vaccines: still a long way to go.
    Gradoni L
    Vet Parasitol; 2015 Feb; 208(1-2):94-100. PubMed ID: 25620293
    [TBL] [Abstract][Full Text] [Related]  

  • 20. During canine viscero-cutaneous leishmaniasis the anti-Hsp70 antibodies are specifically elicited by the parasite protein.
    Quijada L; Requena JM; Soto M; Alonso C
    Parasitology; 1996 Mar; 112 ( Pt 3)():277-84. PubMed ID: 8728991
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 10.